[{"Assets_0_Q1_USD":989799000.0,"CIK":"1743881","CommonStockSharesConverted_0_Q1_shares":123774536.0,"CommonStockSharesOutstanding_0_Q1_shares":121359855.0,"Country":"United States","EarningsPerShareBasic_1_Q1_USD":-0.78,"Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","Market Cap":"1594164456.0","NetCashProvidedByUsedInOperatingActivitiesConverted_1_Q1_USD":-83920000.0,"NetIncomeLossConverted_1_Q1_USD":-91850000.0,"OfficialName":"BridgeBio Pharma Inc. Common Stock","SP500":"nan","Sector":"Health Care","StockholdersEquityConverted_0_Q1_USD":449018000.0,"StockholdersEquity_0_Q1_USD":380715000.0,"Ticker":"BBIO","filed":"20200514","footnote":"nan","form":"10-Q","fp":"Q1","fy":"2020.0","name":"BRIDGEBIO PHARMA, INC.","period":"20200331","qtrs":"0","uom":"USD"}]